Loading company
SCICLONE PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $160.1 million | $157.3 million | +1.8% | 10-K 2017-03-09 · proof |
| Operating income | $33.2 million | $29.9 million | +11.1% | 10-K 2017-03-09 · proof |
| Net income | $30.7 million | $29.5 million | +4.3% | 10-K 2017-03-09 · proof |
| Cash from operating activities | $34.5 million | $32.5 million | +6.2% | 10-K 2017-03-09 · proof |
| Free cash flow | $33.9 million | $30.7 million | +10.5% | 10-K 2017-03-09 · proof |
| Total assets | $241.9 million | $216.6 million | +11.7% | 10-K 2017-03-09 · proof |
| Total liabilities | $26.5 million | $36.9 million | -28.1% | 10-K 2017-03-09 · proof |
| Cash and cash equivalents | $134.4 million | $101.4 million | +32.5% | 10-K 2017-03-09 · proof |
- What was SCICLONE PHARMACEUTICALS INC's revenue in fiscal 2016?
- SCICLONE PHARMACEUTICALS INC reported revenue of $160.1 million for fiscal 2016 (the year ended Dec 31, 2016), against $157.3 million the year before (+1.8%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
- What was SCICLONE PHARMACEUTICALS INC's operating income in fiscal 2016?
- SCICLONE PHARMACEUTICALS INC reported operating income of $33.2 million for fiscal 2016 (the year ended Dec 31, 2016), against $29.9 million the year before (+11.1%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
- What was SCICLONE PHARMACEUTICALS INC's net income in fiscal 2016?
- SCICLONE PHARMACEUTICALS INC reported net income of $30.7 million for fiscal 2016 (the year ended Dec 31, 2016), against $29.5 million the year before (+4.3%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
- What was SCICLONE PHARMACEUTICALS INC's cash from operating activities in fiscal 2016?
- SCICLONE PHARMACEUTICALS INC reported cash from operating activities of $34.5 million for fiscal 2016 (the year ended Dec 31, 2016), against $32.5 million the year before (+6.2%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
- What was SCICLONE PHARMACEUTICALS INC's free cash flow in fiscal 2016?
- SCICLONE PHARMACEUTICALS INC reported free cash flow of $33.9 million for fiscal 2016 (the year ended Dec 31, 2016), against $30.7 million the year before (+10.5%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
- What are SCICLONE PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2016, SCICLONE PHARMACEUTICALS INC reported total assets of $241.9 million, against $216.6 million a year earlier (+11.7%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
- What are SCICLONE PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2016, SCICLONE PHARMACEUTICALS INC reported total liabilities of $26.5 million, against $36.9 million a year earlier (-28.1%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
- What are SCICLONE PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2016, SCICLONE PHARMACEUTICALS INC reported cash and cash equivalents of $134.4 million, against $101.4 million a year earlier (+32.5%). Source: the 10-K filed with the SEC on Mar 9, 2017. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:880771&period_type=annual&limit=5"Information only, not investment advice.